885 related articles for article (PubMed ID: 28708859)
1. Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis.
Couderc E; Morel F; Levillain P; Buffière-Morgado A; Camus M; Paquier C; Bodet C; Jégou JF; Pohin M; Favot L; Garcia M; Huguier V; Mcheik J; Lacombe C; Yssel H; Guillet G; Bernard FX; Lecron JC
PLoS One; 2017; 12(7):e0181486. PubMed ID: 28708859
[TBL] [Abstract][Full Text] [Related]
2. Serum amyloid A induces interleukin-1β secretion from keratinocytes via the NACHT, LRR and PYD domains-containing protein 3 inflammasome.
Yu N; Liu S; Yi X; Zhang S; Ding Y
Clin Exp Immunol; 2015 Feb; 179(2):344-53. PubMed ID: 25231464
[TBL] [Abstract][Full Text] [Related]
3. Suppression of IL-17A-induced CCL20 production by cytokine inducible SH2-containing protein 1 in epidermal keratinocytes.
Tohyama M; Matsumoto A; Tsuda T; Dai X; Shiraishi K; Sayama K
J Dermatol Sci; 2021 Mar; 101(3):202-209. PubMed ID: 33509657
[TBL] [Abstract][Full Text] [Related]
4. Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC)/macrophage inflammatory protein (MIP)-3 alpha/CCL20 by epidermal keratinocytes and its role in atopic dermatitis.
Nakayama T; Fujisawa R; Yamada H; Horikawa T; Kawasaki H; Hieshima K; Izawa D; Fujiie S; Tezuka T; Yoshie O
Int Immunol; 2001 Jan; 13(1):95-103. PubMed ID: 11133838
[TBL] [Abstract][Full Text] [Related]
5. Human keratinocytes respond to interleukin-18: implication for the course of chronic inflammatory skin diseases.
Wittmann M; Purwar R; Hartmann C; Gutzmer R; Werfel T
J Invest Dermatol; 2005 Jun; 124(6):1225-33. PubMed ID: 15955098
[TBL] [Abstract][Full Text] [Related]
6. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines.
Giustizieri ML; Mascia F; Frezzolini A; De Pità O; Chinni LM; Giannetti A; Girolomoni G; Pastore S
J Allergy Clin Immunol; 2001 May; 107(5):871-7. PubMed ID: 11344355
[TBL] [Abstract][Full Text] [Related]
7. Involvement of IL-17F via the induction of IL-6 in psoriasis.
Fujishima S; Watanabe H; Kawaguchi M; Suzuki T; Matsukura S; Homma T; Howell BG; Hizawa N; Mitsuya T; Huang SK; Iijima M
Arch Dermatol Res; 2010 Sep; 302(7):499-505. PubMed ID: 20148256
[TBL] [Abstract][Full Text] [Related]
8. Leptin deficiency in mice counteracts imiquimod (IMQ)-induced psoriasis-like skin inflammation while leptin stimulation induces inflammation in human keratinocytes.
Stjernholm T; Ommen P; Langkilde A; Johansen C; Iversen L; Rosada C; Stenderup K
Exp Dermatol; 2017 Apr; 26(4):338-345. PubMed ID: 27488462
[TBL] [Abstract][Full Text] [Related]
9. Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice.
Kanemaru K; Matsuyuki A; Nakamura Y; Fukami K
Exp Dermatol; 2015 Jun; 24(6):436-42. PubMed ID: 25777289
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of Cathepsin B Reduces Proliferation and Inflammatory Response and Facilitates Differentiation in Human HaCaT Keratinocytes, Ameliorating IL-17A and SAA-Induced Psoriasis-Like Lesion.
Xu D; Wang J
Inflammation; 2021 Oct; 44(5):2006-2017. PubMed ID: 34037897
[TBL] [Abstract][Full Text] [Related]
11. Cyr61/CCN1 induces CCL20 production by keratinocyte via activating p38 and JNK/AP-1 pathway in psoriasis.
Li H; Li H; Huo R; Wu P; Shen Z; Xu H; Shen B; Li N
J Dermatol Sci; 2017 Oct; 88(1):46-56. PubMed ID: 28602508
[TBL] [Abstract][Full Text] [Related]
12. Chronic Alcohol Consumption Exacerbates the Severity of Psoriasiform Dermatitis in Mice.
Vasseur P; Pohin M; Gisclard C; Jégou JF; Morel F; Silvain C; Lecron JC
Alcohol Clin Exp Res; 2020 Sep; 44(9):1728-1733. PubMed ID: 32583876
[TBL] [Abstract][Full Text] [Related]
13. Anti-psoriasis effect of 18β-glycyrrhetinic acid by breaking CCL20/CCR6 axis through its vital active group targeting GUSB/ATF2 signaling.
Wei J; Zhang J; Hu F; Zhang W; Wu Y; Liu B; Lu Y; Li L; Han L; Lu C
Phytomedicine; 2024 Jun; 128():155524. PubMed ID: 38552435
[TBL] [Abstract][Full Text] [Related]
14. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells.
Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC
J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999
[TBL] [Abstract][Full Text] [Related]
15. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
[TBL] [Abstract][Full Text] [Related]
16. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
[TBL] [Abstract][Full Text] [Related]
17. Decreased Expression of Caveolin-1 Contributes to the Pathogenesis of Psoriasiform Dermatitis in Mice.
Yamaguchi Y; Watanabe Y; Watanabe T; Komitsu N; Aihara M
J Invest Dermatol; 2015 Nov; 135(11):2764-2774. PubMed ID: 26134945
[TBL] [Abstract][Full Text] [Related]
18. GILZ regulates Th17 responses and restrains IL-17-mediated skin inflammation.
Jones SA; Perera DN; Fan H; Russ BE; Harris J; Morand EF
J Autoimmun; 2015 Jul; 61():73-80. PubMed ID: 26077873
[TBL] [Abstract][Full Text] [Related]
19. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production.
Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ
Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108
[TBL] [Abstract][Full Text] [Related]
20. Lipocalin-2 exacerbates psoriasiform skin inflammation by augmenting T-helper 17 response.
Hau CS; Kanda N; Tada Y; Shibata S; Uozaki H; Fukusato T; Sato S; Watanabe S
J Dermatol; 2016 Jul; 43(7):785-94. PubMed ID: 26702876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]